SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Trading Update

20 Dec 2019 07:00

RNS Number : 5669X
Warpaint London PLC
20 December 2019
 

20 December 2019

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

Trading Update

 

Change of Executive Director Positions

 

 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, provides an update on the trading performance for the year ending 31 December 2019 and announces a splitting of the positions of the Joint Chief Executives.

 

Trading Update

 

The Company's board is pleased to announce that it currently anticipates that Group sales for the financial year to 31 December 2019 will be approximately £50 million, in line with the guidance provided in the Company's trading update on 6 August 2019.

 

As the Company has previously outlined, a number of factors, including the geographic mix of sales, adverse exchange rate movements and the Group's investment in its strategy for future growth, particularly in the US, are having an impact on profitability in the current financial year. Consequently, the Company's board currently expects adjusted profit before tax for the year ending 31 December 2019 (excluding amortisation in connection with acquisitions, share incentive scheme costs and exceptional items, which the board expects to total approximately £2.8 million) will now be in the range of £5.1 million to £5.5 million.

 

Exchange rate movements in recent months have had a negative impact of approximately £250,000, from a translational perspective, on profitability since the Company's last update in September 2019. This, coupled with further negative margin impact, has led to this reduction in the expected adjusted profit before tax for the current financial year from the previously anticipated range of £6 million to £7 million.

 

Change of Executive Director Positions

 

Following a review of the senior roles within the Company it has been decided that from 1 January 2020 the positions of the Joint Chief Executives will be split, with Sam Bazini remaining as Chief Executive and Eoin Macleod being appointed to the newly created position of Managing Director, reflecting his more operational focus. Both Sam Bazini and Eoin Macleod remain significant shareholders and as executive directors of the Company on its board.

 

Commenting, Clive Garston, Chairman of Warpaint, said: "I am pleased that we anticipate reporting sales for the current financial year in line with the guidance we provided in August. Whilst the unprecedented volatility in exchange rates in recent months has had a negative impact on the profits of the Company, both from a translational and margin perspective, I am pleased by our overall trading performance.

 

"Following a review of the roles being undertaken by our Joint Chief Executives we have decided to formally split the role. Sam and Eoin have always split the Chief Executive role so that they have distinct responsibilities within the Company, but with the Company's growth and diversification since admission to AIM we think these new positions are now an appropriate way to formally reflect this.

 

"With the Company's robust balance sheet, profitable trading performance and strategy for growth we continue to look forward to the new year with confidence."

 

Enquiries:

 

Warpaint London

Sam Bazini - Joint Chief Executive Officer

Eoin Macleod - Joint Chief Executive Officer

Neil Rodol - Chief Financial Officer

c/o IFC

 

 

Shore Capital (Nominated Adviser and Joint Broker)

Antonio Bossi - Corporate Advisory

Fiona Conroy - Corporate Broking

 

 

020 7408 4090

N+1 Singer (Joint Broker)

Shaun Dobson - Corporate Finance

Alex Bond - Corporate Finance

Mia Gardner - Corporate Broking

020 7496 3000

 

 

IFC Advisory (Financial PR & IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

020 3934 6630

 

 

 

 

 

Warpaint London plc

 

Warpaint London plc is made up of two divisions.

 

The largest division sells cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to discount retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and the rest of Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, this division supplies white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using the smaller brand names of Man'stuff, Body Collection, Vintage, Outdoor Girl, Very Vegan, Chit Chat, Smooch, Copy Cat and Taxi.

 

The second division trades in close-out and excess stock of other branded cosmetics and fragrances from around the world.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFUFUUFUSEDE
Date   Source Headline
29th Oct 20187:00 amRNSTrading Update
4th Oct 20185:30 pmEQSHardman & Co Research: Warpaint London Plc (W7L): 1H'18 interims: delivering the results
4th Oct 20185:10 pmEQSHardman & Co Research: Diurnal Group (DNL): First commercial revenues
24th Sep 20187:00 amRNSImplementation of Long-term Incentive Plan
21st Sep 20184:37 pmRNSHolding(s) in Company
17th Sep 20187:00 amRNSAppointment of Director
17th Sep 20187:00 amRNSInterim Results for the 6 months to 30 June 2018
3rd Sep 20187:00 amRNSNotice of Results
3rd Aug 20187:00 amRNSAcquisition of USA Distributor
19th Jun 20187:00 amRNSDirector Dealings
13th Jun 20182:43 pmEQSHardman & Co Research: Warpaint London PLC (W7L): Painting a bright future
12th Jun 201812:40 pmRNSResult of AGM
12th Jun 20187:00 amRNSAGM Statement
18th May 20182:45 pmRNSPosting of Annual Report and Notice of AGM
2nd May 20187:00 amRNSHolding(s) in Company
2nd May 20187:00 amRNSHolding(s) in Company
25th Apr 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
24th Apr 20187:00 amRNSQueen?s Award for International Trade
11th Apr 20187:00 amRNSNotice of Results
2nd Mar 20182:37 pmRNSHolding(s) in Company
7th Feb 20187:00 amRNSTrading Update
4th Dec 20174:03 pmRNSHolding(s) in Company
1st Dec 201712:34 pmRNSDirector Declaration
30th Nov 20178:48 amRNSCompletion of the Acquisition of Retra
29th Nov 201712:12 pmRNSResult of General Meeting
13th Nov 201711:57 amRNSResults of Placing
13th Nov 20177:00 amRNSAcquisition and Placing to raise up to £21.2m
20th Sep 20172:50 pmRNSHolding(s) in Company
14th Sep 20174:40 pmRNSSecond Price Monitoring Extn
14th Sep 20174:35 pmRNSPrice Monitoring Extension
14th Sep 20177:00 amRNSInterim Results - six months ended 30 June 2017
5th Sep 201710:00 amRNSNotice of Results
7th Aug 20174:35 pmRNSPrice Monitoring Extension
30th Jun 20177:00 amRNSGrant of Options and Director Dealing
26th Jun 201711:00 amRNSResult of AGM
26th Jun 20177:00 amRNSAGM Statement
9th Jun 20172:40 pmRNSHolding(s) in Company
2nd Jun 201710:04 amRNSPosting of Annual Report / Notice of AGM
22nd May 201712:46 pmRNSDirector Dealings
10th May 20177:00 amRNSFinal results for the year ended 31 December 2016
31st Mar 20177:00 amRNSNotice of Results
1st Mar 20177:00 amRNSAppointment of Company Secretary
8th Dec 20164:14 pmRNSHolding(s) in Company
5th Dec 20167:00 amRNSHolding(s) in Company
2nd Dec 201611:03 amRNSHolding(s) in Company
30th Nov 20167:00 amRNSAdmission to AIM & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.